Amneal Pharmaceuticals (AMRX) Enterprise Value (2018 - 2026)
Amneal Pharmaceuticals' Enterprise Value was $5.48 billion in Q2 2026, up 116.3% from $2.54 billion a year earlier and up 42.3% from the prior quarter.
Amneal Pharmaceuticals (AMRX) Enterprise Value (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Amneal Pharmaceuticals' Enterprise Value was $4.8 billion through Jun 30, 2026, up 109.6% year-over-year; for FY2025, it was $3.76 billion, up 56.0% from FY2024.
- Enterprise Value has now increased for three consecutive years, with a five-year compound annual growth rate of 29.3% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $2.41 billion in FY2024 (+33.1%), $1.81 billion in FY2023 (+200.1%), $603.15 million in FY2022 (-50.3%) and $1.21 billion in FY2021 (+16.6%).
- The Q2 2026 figure marks the highest quarterly Enterprise Value since Q3 2018.
- Compared with a year earlier, Enterprise Value has increased for 12 straight quarters, with growth averaging 55.6% over the last eight quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q1 2024 (growth of 508.6%); the worst was Q1 2023 (a decline of 71.2%).
- Per Business Quant data, AMRX's Enterprise Value in the three quarters before Q2 2026 was $3.85 billion (Q1 2026), $3.76 billion (Q4 2025) and $3.01 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,148.26 Bn | 1,116.85 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.74 Bn | 543.27 Bn | 17.26 Bn |
| 3 | AbbVie | 509.56 Bn | 482.67 Bn | 12.70 Bn |
| 4 | Merck | 366.23 Bn | 320.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.81 Bn | 261.80 Bn | 11.24 Bn |
| 6 | Astrazeneca | 262.30 Bn | 235.98 Bn | 12.86 Bn |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.42 Bn | 168.61 Bn | 6.22 Bn |
| 9 | Pfizer | 172.08 Bn | 118.73 Bn | 10.94 Bn |
| 10 | Amneal Pharmaceuticals | 6.33 Bn | 5.52 Bn | 334.51 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.48 Bn |
| Mar 31, 2026 | 3.85 Bn |
| Dec 31, 2025 | 3.76 Bn |
| Sep 30, 2025 | 3.01 Bn |
| Jun 30, 2025 | 2.54 Bn |
| Mar 31, 2025 | 2.64 Bn |
| Dec 31, 2024 | 2.41 Bn |
| Sep 30, 2024 | 2.56 Bn |
| Jun 30, 2024 | 1.98 Bn |
| Mar 31, 2024 | 1.87 Bn |
| Dec 31, 2023 | 1.81 Bn |
| Sep 30, 2023 | 1.24 Bn |
| Jun 30, 2023 | 871.94 Mn |
| Mar 31, 2023 | 307.43 Mn |
| Dec 31, 2022 | 603.15 Mn |
| Sep 30, 2022 | 548.20 Mn |
| Jun 30, 2022 | 891.12 Mn |
| Mar 31, 2022 | 1.07 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Sep 30, 2021 | 1.32 Bn |
Amneal Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=AMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();